High-Throughput Screening of Saliva for Early Detection of Oral Cancer: A Pilot Study
Open Access
- 1 April 2012
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 11 (2) , 181-188
Abstract
The success of tumour therapy depends considerably on early diagnosis. Therefore, we aimed to develop a widely available, cheap, non-invasive, high-throughput method suitable for screening high-risk populations, at least, for early signs of malignant transformation in the oral cavity. First, in order to identify suitable tumour marker candidates, we compared the protein patterns of five selected saliva samples obtained from healthy controls and tumour patients after electrophoretic separation, excised the bands that were consistently up-regulated in the tumour patients only, and performed matrix-assisted laser-desorption ionisation (MALDI)-time of flight (TOF) tandem mass spectrometry (MS/MS) analysis of the proteins in these bands after in-gel tryptic digestion. From the panel of proteins identified, we chose annexin 1 and peroxiredoxin 2 for further studies based on their presence in the saliva of all five oral cancer patients only. Then, we performed a homology search of protein databases using the primary sequence of each in silico tryptic fragment peptide of these two proteins as bait, and selected a unique peptide for each. Finally, we performed targeted MALDI-TOF MS peptide analysis in a blinded fashion on all samples obtained from 20 healthy controls and 22 tumour patients for the presence of these peptides. We found both peptides present in the saliva samples of all cancer patients only. Even though these tumour markers should be validated in a wider population, our results indicate that targeted MALDI-TOF MS analysis of unique peptides of putative saliva protein tumour biomarkers could be the method of choice for cost-efficient, high-throughput screening for the early detection of oral cancer.Keywords
This publication has 18 references indexed in Scilit:
- Systematic comparison of the human saliva and plasma proteomesProteomics – Clinical Applications, 2009
- Laser‐induced autofluorescence spectral ratio reference standard for early discrimination of oral cancerCancer, 2008
- Proteomics Analysis of Cells in Whole Saliva from Oral Cancer Patients via Value-added Three-dimensional Peptide Fractionation and Tandem Mass SpectrometryMolecular & Cellular Proteomics, 2008
- Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinomaJournal of Surgical Oncology, 2008
- Proteomics: Clinical applications for head and neck squamous cell carcinomaHead & Neck, 2006
- Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer PatientsJNCI: Journal of the National Cancer Institute, 2006
- Deciphering Protein Molecular Signatures in Cancer Tissues to Aid in Diagnosis, Prognosis, and TherapyCancer Research, 2005
- A Catalogue of Human Saliva Proteins Identified by Free Flow Electrophoresis-based Peptide Separation and Tandem Mass SpectrometryMolecular & Cellular Proteomics, 2005
- Identification of Protein Components in Human Acquired Enamel Pellicle and Whole Saliva Using Novel Proteomics ApproachesJournal of Biological Chemistry, 2003
- Saliva: its secretion, composition and functionsBritish Dental Journal, 1992